Research ArticleOriginal Article
Open Access

Correlation between plasma glutathione peroxidase 4 and N-acetylneuraminic acid levels with clinical risk stratification and prognosis of patients with acute coronary syndrome

Miao-Nan Li, Bing-Wei Bao, Ding Si-Yu, Ji Chun-Fei, Shi Xiao-Jun, Gao Da-Sheng, Gao Qin and Wang Hong-Ju
Saudi Medical Journal October 2022, 43 (10) 1103-1110; DOI: https://doi.org/10.15537/smj.2022.43.10.20220444

References

  1. 1.↵
    1. Eisen A,
    2. Giugliano RP,
    3. Braunwald E.
    Updates on acute coronary syndrome: a review. JAMA Cardiol 2016; 1: 718-730.
    OpenUrl
  2. 2.↵
    1. Sinha SK,
    2. Goel A,
    3. Madaan A,
    4. Thakur R,
    5. Krishna V,
    6. Singh K, et al.
    Prevalence of metabolic syndrome and its clinical and angiographic profile in patients with naive acute coronary syndrome in North Indian population. J Clin Med Res 2016; 8: 667-673.
    OpenUrl
  3. 3.↵
    1. Zaliūnas R,
    2. Slapikas R,
    3. Luksiene D,
    4. Slapikiene B,
    5. Statkeviciene A,
    6. Milvidaite I, et al.
    Prevalence of metabolic syndrome components in patients with acute coronary syndromes. Medicina (Kaunas) 2008; 44: 182-188.
    OpenUrlPubMed
  4. 4.↵
    1. Zhang Y,
    2. Ren X,
    3. Wang Y,
    4. Chen D,
    5. Jiang L,
    6. Li X, et al.
    Targeting ferroptosis by polydopamine nanoparticles protects heart against ischemia/reperfusion injury. ACS Appl Mater Interfaces 2021; 13: 53671-53682.
    OpenUrl
  5. 5.
    1. Menon AV,
    2. Liu J,
    3. Tsai HP,
    4. Zeng L,
    5. Yang S,
    6. Asnani A, et al.
    Excess heme upregulates heme oxygenase 1 and promotes cardiac ferroptosis in mice with sickle cell disease. Blood 2022; 139: 936-941.
    OpenUrl
  6. 6.↵
    1. Park TJ,
    2. Park JH,
    3. Lee GS,
    4. Lee JY,
    5. Shin JH,
    6. Kim MW, et al.
    Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes. Cell Death Dis 2019; 10: 835.
    OpenUrl
  7. 7.↵
    1. Savaskan NE,
    2. Ufer C,
    3. Kühn H,
    4. Borchert A.
    Molecular biology of glutathione peroxidase 4: from genomic structure to developmental expression and neural function. Biol Chem 2007; 388: 1007-1017.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Yoo MH,
    2. Gu X,
    3. Xu XM,
    4. Kim JY,
    5. Carlson BA,
    6. Patterson AD, et al.
    Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in Alzheimer’s disease. Antioxid Redox Signal 2010; 12: 819-827.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.
    1. Bellinger FP,
    2. Bellinger MT,
    3. Seale LA,
    4. Takemoto AS,
    5. Raman AV,
    6. Miki T, et al.
    Glutathione peroxidase 4 is associated with neuromelanin in substantia nigra and dystrophic axons in putamen of Parkinson’s brain. Mol Neurodegener 2011; 6: 8.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Necheles TF,
    2. Boles TA,
    3. Allen DM.
    Erythrocyte glutathione-peroxidase deficiency and hemolytic disease of the newborn infant. Journal of Pediatrics 1968; 72: 319-324.
    OpenUrlCrossRefWeb of Science
  11. 11.↵
    1. Fang X,
    2. Wang H,
    3. Han D,
    4. Xie E,
    5. Yang X,
    6. Wei J, et al.
    Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A 2019; 116: 2672-2680.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Li C,
    2. Deng X,
    3. Xie X,
    4. Liu Y,
    5. Friedmann Angeli JP,
    6. Lai L.
    Activation of glutathione peroxidase 4 as a novel anti-inflammatory strategy. Front Pharmacol 2018; 9: 1120.
    OpenUrl
  13. 13.↵
    1. Blankenberg S,
    2. Rupprecht HJ,
    3. Bickel C,
    4. Torzewski M,
    5. Hafner G,
    6. Tiret L, et al.
    Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 2003; 349: 1605-1613.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Holley A,
    2. Pitman J,
    3. Miller J,
    4. Harding S,
    5. Larsen P.
    Glutathione peroxidase activity and expression levels are significantly increased in acute coronary syndromes. J Investig Med 2017; 65: 919-925.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Zhou X,
    2. Yang G,
    3. Guan F.
    Biological functions and analytical strategies of sialic acids in tumor. Cells 2020; 9: 273.
    OpenUrlCrossRef
  16. 16.↵
    1. Hu W,
    2. Xie J,
    3. Zhu T,
    4. Meng G,
    5. Wang M,
    6. Zhou Z, et al.
    Serum N-acetylneuraminic acid is associated with atrial fibrillation and left atrial enlargement. Cardiol Res Pract 2020; 2020: 1358098.
    OpenUrl
  17. 17.↵
    1. Li MN,
    2. Qian SH,
    3. Yao ZY,
    4. Ming SP,
    5. Shi XJ,
    6. Kang PF, et al.
    Correlation of serum N-acetylneuraminic acid with the risk and prognosis of acute coronary syndrome: a prospective cohort study. BMC Cardiovasc Disord 2020; 20: 404.
    OpenUrl
  18. 18.↵
    Chinese Society of Cardiology of Chinese Medical Association; Editorial Board of Chinese Journal of Cardiology. [Guideline and consensus for the management of patients with non-ST-elevation acute coronary syndrome(2016)]. Zhonghua Xin Xue Guan Bing Za Zhi 2017; 45: 359-376. [ In Chinese]
    OpenUrl
  19. 19.↵
    Chinese Society of Cardiology of Chinese Medical Association; Editorial Board of Chinese Journal of Cardiology. [2019 Chinese Society of Cardiology (CSC) guidelines for the diagnosis and management of patients with ST-segment elevation myocardial infarction]. Zhonghua Xin Xue Guan Bing Za Zhi 2019; 47: 766-783. [ In Chinese]
    OpenUrl
  20. 20.↵
    1. Smith SC Jr.,
    2. Dove JT,
    3. Jacobs AK,
    4. Kennedy JW,
    5. Kereiakes D,
    6. Kern MJ, et al.
    ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation 2001; 103: 3019-3041.
    OpenUrlFREE Full Text
  21. 21.↵
    1. Chen MJ,
    2. Chiou YY,
    3. Wu DC,
    4. Wu SL.
    Lifestyle habits and gastric cancer in a hospital-based case-control study in Taiwan. Am J Gastroenterol 2000; 95: 3242-3249.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care 2021; 44: S15-S33.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Unger T,
    2. Borghi C,
    3. Charchar F,
    4. Khan NA,
    5. Poulter NR,
    6. Prabhakaran D, et al.
    2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 2020; 75: 1334-1357.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Hindricks G,
    2. Potpara T,
    3. Dagres N,
    4. Arbelo E,
    5. Bax JJ,
    6. Blomström-Lundqvist C, et al.
    2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021; 42: 373-498.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Fang M,
    2. Xu X,
    3. Zhang M,
    4. Shi Y,
    5. Gu G,
    6. Liu W, et al.
    Quantitation of cytidine-5’-monophospho-N-acetylneuraminic acid in human leukocytes using LC-MS/MS: method development and validation. Biomed Chromatogr 2020; 34: e4735.
    OpenUrl
  26. 26.↵
    1. Rehm S,
    2. Rentsch KM.
    A 2D HPLC-MS/MS method for several antibiotics in blood plasma, plasma water, and diverse tissue samples. Anal Bioanal Chem 2020; 412: 715-725.
    OpenUrl
  27. 27.↵
    1. Page HL Jr.
    The Judkin’s technique. Cathet Cardiovasc Diagn 1979; 5: 187-189.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Gensini GG.
    A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Antman EM,
    2. Cohen M,
    3. Bernink PJ,
    4. McCabe CH,
    5. Horacek T,
    6. Papuchis G, et al.
    The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000; 284: 835-842.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Morrow DA,
    2. Antman EM,
    3. Charlesworth A,
    4. Cairns R,
    5. Murphy SA,
    6. de Lemos JA, et al.
    TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000; 102: 2031-2037.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Baluja A,
    2. Rodríguez-Mañero M,
    3. Cordero A,
    4. Kreidieh B,
    5. Iglesias-Alvarez D,
    6. García-Acuña JM, et al.
    Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome. Diab Vasc Dis Res 2020; 17: 1479164119892137.
    OpenUrl
  32. 32.↵
    1. Mueller C.
    Biomarkers and acute coronary syndromes: an update. Eur Heart J 2014; 35: 552-556.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Vichova T,
    2. Motovska Z.
    Oxidative stress: predictive marker for coronary artery disease. Exp Clin Cardiol 2013; 18: e88-e91.
    OpenUrlPubMed
  34. 34.↵
    1. Friedmann Angeli JP,
    2. Conrad M.
    Selenium and GPX4, a vital symbiosis. Free Radic Biol Med 2018; 127: 153-159.
    OpenUrl
  35. 35.
    1. Bebber CM,
    2. Müller F,
    3. Prieto Clemente L,
    4. Weber J,
    5. von Karstedt S.
    Ferroptosis in cancer cell biology. Cancers (Basel) 2020; 12: 164.
    OpenUrl
  36. 36.↵
    1. Han D,
    2. Jiang L,
    3. Gu X,
    4. Huang S,
    5. Pang J,
    6. Wu Y, et al.
    SIRT3 deficiency is resistant to autophagy-dependent ferroptosis by inhibiting the AMPK/mTOR pathway and promoting GPX4 levels. J Cell Physiol 2020; 235: 8839-8851.
    OpenUrl
  37. 37.↵
    1. Park SS.
    Post-glycosylation modification of sialic acid and its role in virus pathogenesis. Vaccines (Basel) 2019; 7: 171.
    OpenUrl
  38. 38.↵
    1. Fu H,
    2. Zhu K,
    3. Zhou D,
    4. Guan Y,
    5. Li W,
    6. Xu S.
    Identification and validation of plasma metabolomics reveal potential biomarkers for coronary heart disease. Int Heart J 2019; 60: 1387-1397.
    OpenUrl
  39. 39.↵
    1. Orlenko A,
    2. Kofink D,
    3. Lyytikäinen LP,
    4. Nikus K,
    5. Mishra P,
    6. Kuukasjärvi P, et al.
    Model selection for metabolomics: predicting diagnosis of coronary artery disease using automated machine learning. Bioinformatics 2020; 36: 1772-1778.
    OpenUrlCrossRef
  40. 40.↵
    1. Zhang C,
    2. Chen J,
    3. Liu Y,
    4. Xu D.
    Sialic acid metabolism as a potential therapeutic target of atherosclerosis. Lipids Health Dis 2019; 18: 173.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords